1. Home
  2. CRBU vs CPSS Comparison

CRBU vs CPSS Comparison

Compare CRBU & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.45

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

HOLD

Current Price

$8.89

Market Cap

201.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRBU
CPSS
Founded
2011
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
203.9M
201.5M
IPO Year
2021
1992

Fundamental Metrics

Financial Performance
Metric
CRBU
CPSS
Price
$1.45
$8.89
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
1.1M
18.0K
Earning Date
03-09-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.80
Revenue
$9,295,000.00
$196,531,000.00
Revenue This Year
$0.22
$139.62
Revenue Next Year
$4.48
$10.58
P/E Ratio
N/A
$10.87
Revenue Growth
N/A
6.67
52 Week Low
$0.66
$6.67
52 Week High
$3.54
$12.73

Technical Indicators

Market Signals
Indicator
CRBU
CPSS
Relative Strength Index (RSI) 34.21 44.39
Support Level $1.52 $8.70
Resistance Level $1.63 $9.57
Average True Range (ATR) 0.08 0.29
MACD -0.00 -0.06
Stochastic Oscillator 7.14 12.35

Price Performance

Historical Comparison
CRBU
CPSS

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

Share on Social Networks: